Literature DB >> 20404252

Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study.

Anders G Holst1, Gorm Jensen, Eva Prescott.   

Abstract

BACKGROUND: Studies have suggested a link between risk factors for atherosclerotic disease and venous thromboembolism (VTE), but results are heterogeneous. We sought to identify risk factors for VTE with a focus on risk factors for atherosclerotic disease. METHODS AND
RESULTS: Data were taken from the Copenhagen City Heart Study, a prospective cohort study of a random, age-stratified sample of people living in a defined area in Copenhagen, Denmark, started in 1976 with follow-up until 2007. First VTE (deep vein thrombosis and pulmonary embolism) diagnosis was retrieved from electronic national registries from study baseline to 2007. Of 18 954 subjects (median follow-up, 19.5 years) representing 360 399 person-years of follow-up, 969 subjects experienced at least 1 VTE, corresponding to a crude incidence rate of 2.69 (95% confidence interval [CI], 2.52 to 2.86) per 1000 person-years. The variables found to be significantly associated with VTE in a multivariable model adjusted for age and calendar time were as follows: body mass index (hazard ratio [HR] for >or=35 versus <20=2.10 [95% CI, 1.39 to 3.16]); smoking (HR for >or=25 g tobacco per day versus never smoker=1.52 [95% CI, 1.15 to 2.01]); gender (HR for men versus women=1.24 [95% CI, 1.08 to 1.42]); household income (HR for medium versus low=0.82 [95% CI, 0.70 to 0.95]); and diastolic blood pressure (HR for >100 versus <80 mm Hg=1.34 [95% CI, 1.08 to 1.66]). Other cardiovascular risk factors including total/high-density lipoprotein/low-density lipoprotein cholesterol levels, triglyceride levels, and diabetes mellitus were not associated with VTE.
CONCLUSIONS: Obesity and smoking were both found to be important risk factors for VTE whereas total/high-density lipoprotein/low-density lipoprotein cholesterol levels, triglyceride levels, and diabetes mellitus were not.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404252     DOI: 10.1161/CIRCULATIONAHA.109.921460

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  95 in total

1.  Venous thromboembolism in patients with membranous nephropathy.

Authors:  Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal:  Clin J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 8.237

2.  Impact of obesity on the risk of venous thromboembolism in an inpatient pediatric population.

Authors:  Sean Stokes; Patrick Breheny; Aurelia Radulescu; Vlad Calin Radulescu
Journal:  Pediatr Hematol Oncol       Date:  2014-03-31       Impact factor: 1.969

3.  Late failure of a split-thickness skin graft in the setting of homozygous factor V Leiden mutation: a case report and correlative animal model from the Wound Etiology and Healing (WE-HEAL) study.

Authors:  Victoria K Shanmugam; Sean McNish; Joanna Duncan; Brandy Root; Elena Tassi; Anton Wellstein; Bhaskar Kallakury; Christopher E Attinger
Journal:  Int Wound J       Date:  2013-09-13       Impact factor: 3.315

4.  Race, ABO blood group, and venous thromboembolism risk: not black and white.

Authors:  Chunhui Fang; Hillel W Cohen; Henny H Billett
Journal:  Transfusion       Date:  2012-04-27       Impact factor: 3.157

5.  Neighborhood deprivation and hospitalization for venous thromboembolism in Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

6.  [High risk pulmonary embolism. Case report of a successful embolectomy].

Authors:  J Kalbhenn; T Loop; C A Stahl
Journal:  Anaesthesist       Date:  2011-11       Impact factor: 1.041

Review 7.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.

Authors:  Scott D Grosse; Richard E Nelson; Kwame A Nyarko; Lisa C Richardson; Gary E Raskob
Journal:  Thromb Res       Date:  2015-11-24       Impact factor: 3.944

8.  Hypercoagulable state evaluated by thromboelastography in patients with idiopathic membranous nephropathy.

Authors:  Meng-jie Huang; Ri-bao Wei; Qing-ping Li; Xi Yang; Cui-ming Cao; Ting-yu Su; Na Wang; Rui Wang; Xiang-mei Chen
Journal:  J Thromb Thrombolysis       Date:  2016-02       Impact factor: 2.300

9.  Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients.

Authors:  Irene Yu; Leo Chen; Jenny Y Ruan; Jennifer T Chang; Winson Y Cheung
Journal:  Support Care Cancer       Date:  2015-08-19       Impact factor: 3.603

Review 10.  Diabetes mellitus and venous thromboembolism: A systematic review and meta-analysis.

Authors:  Elizabeth J Bell; Aaron R Folsom; Pamela L Lutsey; Elizabeth Selvin; Neil A Zakai; Mary Cushman; Alvaro Alonso
Journal:  Diabetes Res Clin Pract       Date:  2015-11-10       Impact factor: 5.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.